Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001608936-25-000010
Filing Date
2025-10-08
Accepted
2025-10-08 17:35:33
Documents
1
Period of Report
2025-10-06

Document Format Files

Seq Description Document Type Size
1 form4-10082025_091029.html 4  
1 form4-10082025_091029.xml 4 4221
  Complete submission text file 0001608936-25-000010.txt   5690
Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVE., SUITE D SAN DIEGO CA 92121
Business Address
Chacko Jacob (Reporting) CIK: 0001608936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 251383237

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)